These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33342622)

  • 1. The Effect of Statins in Children and Adolescents With Familial Hypercholesterolemia: A Systematic Review.
    Dombalis S; Nash A
    J Pediatr Health Care; 2021; 35(3):292-303. PubMed ID: 33342622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins for children with familial hypercholesterolemia.
    Vuorio A; Kuoppala J; Kovanen PT; Humphries SE; Tonstad S; Wiegman A; Drogari E; Ramaswami U
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD006401. PubMed ID: 28685504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins for children with familial hypercholesterolemia.
    Vuorio A; Kuoppala J; Kovanen PT; Humphries SE; Tonstad S; Wiegman A; Drogari E
    Cochrane Database Syst Rev; 2014 Jul; (7):CD006401. PubMed ID: 25054950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Lozano P; Henrikson NB; Dunn J; Morrison CC; Nguyen M; Blasi PR; Anderson ML; Whitlock EP
    JAMA; 2016 Aug; 316(6):645-55. PubMed ID: 27532919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins for children with familial hypercholesterolemia.
    Vuorio A; Kuoppala J; Kovanen PT; Humphries SE; Tonstad S; Wiegman A; Drogari E; Ramaswami U
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31696945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of colesevelam HCl in the treatment of heterozygous familial hypercholesterolemia in pediatric and adult patients.
    Davidson M
    Clin Ther; 2013 Aug; 35(8):1247-52. PubMed ID: 23916045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins for children with familial hypercholesterolemia.
    Vuorio A; Kuoppala J; Kovanen PT; Humphries SE; Strandberg T; Tonstad S; Gylling H
    Cochrane Database Syst Rev; 2010 Jul; (7):CD006401. PubMed ID: 20614444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma lipoprotein(a) levels and LDL-cholesterol lowering response to statin therapy in patients with heterozygous familial hypercholesterolemia.
    Miltiadous G; Saougos V; Cariolou M; Elisaf MS
    Ann Clin Lab Sci; 2006; 36(3):353-5. PubMed ID: 16951279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Knowns and Unknowns of Contemporary Statin Therapy for Familial Hypercholesterolemia.
    Pang J; Chan DC; Watts GF
    Curr Atheroscler Rep; 2020 Sep; 22(11):64. PubMed ID: 32870376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The UK Paediatric Familial Hypercholesterolaemia Register: Statin-related safety and 1-year growth data.
    Humphries SE; Cooper J; Dale P; Ramaswami U;
    J Clin Lipidol; 2018; 12(1):25-32. PubMed ID: 29208363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cascade screening and treatment of children with familial hypercholesterolemia in Turkey.
    Kose E; Kose M; Ozturk SI; Ozcan E; Onay H; Ozkan B
    J Pediatr Endocrinol Metab; 2020 Aug; 33(10):1251-1256. PubMed ID: 32829317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
    deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
    Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin Treatments And Dosages In Children With Familial Hypercholesterolemia: Meta-Analysis.
    Radaelli G; Sausen G; Cesa CC; Santos FS; Portal VL; Neyeloff JL; Pellanda LC
    Arq Bras Cardiol; 2018 Dec; 111(6):810-821. PubMed ID: 30365601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inborn coagulation factors are more important cardiovascular risk factors than high LDL-cholesterol in familial hypercholesterolemia.
    Ravnskov U; de Lorgeril M; Kendrick M; Diamond DM
    Med Hypotheses; 2018 Dec; 121():60-63. PubMed ID: 30396495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances with lipid-lowering drugs for pediatric patients with familial hypercholesterolemia.
    Ferrari F; Martins VM; Rocha VZ; Santos RD
    Expert Opin Pharmacother; 2021 Mar; 22(4):483-495. PubMed ID: 33016816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary counseling is associated with an improved lipid profile in children with familial hypercholesterolemia.
    Torvik K; Narverud I; Ottestad I; Svilaas A; Gran JM; Retterstøl K; Ellingvåg A; Strøm E; Ose L; Veierød MB; Holven KB
    Atherosclerosis; 2016 Sep; 252():21-27. PubMed ID: 27494447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreasing the Cholesterol Burden in Heterozygous Familial Hypercholesterolemia Children by Dietary Plant Stanol Esters.
    Vuorio A; Kovanen PT
    Nutrients; 2018 Dec; 10(12):. PubMed ID: 30513705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Approach to the Diagnosis and Treatment of Heterozygote and Homozygous FH Children and Adolescents.
    Cohen H; Stefanutti C;
    Curr Atheroscler Rep; 2021 May; 23(6):30. PubMed ID: 33963467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins in the Management of Pediatric Dyslipidemia.
    Ross JL
    J Pediatr Nurs; 2016; 31(6):723-735. PubMed ID: 27496827
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.